// App-Quantinova.ai

: Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?

Researchers

Presenter

  • Gill Gilworth

Principal Investigators

  • Timothy Harries

  • Mike Thomas

  • Christopher Corrigan

  • Patrick Murphy

  • Nicholas Hart

  • Leslie Hamilton

  • Patrick T. White

Medical Centers

  • School of Population Health and Environmental Sciences, King’s College London, London, United Kingdom

  • University of Southampton, Southampten, United Kingdom

  • Department of Asthma, Allergy and Respiratory Science, Kings College London, London, United Kingdom.

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved